|
|
||||||||
1 Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507; and 2 Second Department of Internal Medicine, Jikei University School of Medicine, Tokyo 10-8461, Japan
| |
ABSTRACT |
|---|
|
|
|---|
To elucidate the
significance of oxidative stress in the modulation of endothelial
functions, we examined the effects of H2O2 on
the expression of two endothelium-derived vasoactive peptides, endothelin (ET) and adrenomedullin (Am), and their interaction. H2O2 dose dependently suppressed ET secretion
and ET-1 mRNA expression in bovine carotid endothelial cells (ECs).
Menadion sodium bisulfate, a redox cycling drug, also decreased ET
secretion in a dose-dependent manner. Catalase, a
H2O2 reductase, and
dl-
-tocopherol (vitamin E) significantly inhibited
H2O2-induced suppression of ET secretion. Downregulation of ET-1 mRNA under oxidative stress was regulated at the
transcriptional level. In contrast, H2O2
increased Am secretion (and its mRNA expression) accompanied by the
augmentation of cAMP production. Am, as well as 8-bromo-cAMP and
forskolin decreased ET secretion in a dose-dependent fashion.
Furthermore, an anti-Am monoclonal antibody that we developed abolished
H2O2-induced suppression of ET secretion at
6-24 h after the addition of H2O2.
H2O2 increased the intracellular
Ca2+ concentration ([Ca2+]i).
Moreover, treatment with ionomycin, a Ca2+ ionophore, and
thapsigargin, an inhibitor of endoplasmic reticulum ATPase, decreased
ET secretion dose dependently for 3 h. These results suggest that
the production of ET was decreased via activation of the Am-cAMP
pathway and by the elevation of [Ca2+]i under
oxidative stress. These findings elucidate the coordinate expression of
two local vascular hormones, ET and Am, under oxidative stress, which
may protect against vascular diseases.
intracellular Ca2+; hydrogen peroxide; cAMP; nitric oxide; C-type natriuretic peptide
| |
INTRODUCTION |
|---|
|
|
|---|
THE PHYSIOLOGICAL PRODUCTION OF reactive oxygen species (ROS) such as superoxide and H2O2 is necessary for maintenance of cell function and cell homeostasis. However, a surplus generation of ROS, termed oxidative stress, has been implicated in pathophysiological mechanisms. In the vasculature, oxidative stress has been recently found to play a role in the pathophysiology of hypertension and atherosclerosis. Recent studies have shown that an excess amount of oxidant induces profound vascular endothelial cell (EC) dysfunction such as vascular permeability aggravation via stimulation of platelet-activating factor production (27), abnormal coagulation due to inhibition of prostaglandin I2 synthesis (38), and cell lysis (40).
ECs participate in the regulation of vascular tone and remodeling by modulating the secretion of vasoactive substances. Itoh et al. (18, 19) reported that vasoactive substances regulate not only vascular tone but also vascular growth; i.e., angiotensin II, a potent vasoconstrictor, promotes vascular growth. Furthermore, we elucidated that C-type natriuretic peptide (CNP) is secreted from ECs (24, 37) and regulates vascular remodeling (6, 23, 35, 36).
Endothelin (ET) is a 21-amino acid peptide isolated from the
supernatant of porcine aortic ECs (39). ET exerts potent
cardiovascular actions, the most prominent of which is vascular
constriction. Increased ET-1 expression has been observed after
treatment of cultured ECs with growth factors and cytokines such as
thrombin (7), transforming growth factor-
(25), tumor necrosis factor-
(26), or
insulin (32). Vasoactive substances, such as angiotensin II (5, 15) and antidiuretic hormone (15),
also increase ET-1 mRNA expression in ECs. On the other hand,
cGMP-elevating vasodilators, such as nitric oxide (NO)
(14) and atrial natriuretic peptide (13),
have been known to decrease endothelial ET secretion. Recently, Michael
et al. (29) reported that oxidative stress elicited by
glucose oxidase decreased the expression of ET in cultured rat
pulmonary arterial ECs; however, the mechanisms by which oxidants
regulate ET production remain unclear.
Adrenomedullin (Am), which was first isolated from human pheochromocytoma, is a potent vasorelaxant peptide that is secreted from vascular ECs (21). Am exerts a hypotensive effect and an antiproliferative effect through a cAMP-dependent process (20). Chini et al. (1) reported that Am acts as a cytoprotective autacoid to suppress oxidative stress through the cAMP signaling pathway. In vascular smooth muscle cells (VSMCs), exogeneously administered Am has been reported (22) to suppress ET-1 production.
The intracellular Ca2+ concentration ([Ca2+]i) is an important significant signal transduction in the cardiovascular system. It was reported that oxidants increased [Ca2+]i in ECs (9). Furthermore, treatment with Ca2+ ionophores inhibited ET production in ECs (31). These findings suggest that oxidative stress suppresses ET production by modulating [Ca2+]i. The underlying regulation mechanisms between ET production and [Ca2+]i during oxidative stress are not fully understood.
In the present study, to elucidate the significance of oxidative stress in the modulation of endothelial functions, we examined the effects of H2O2 on the expression of two endothelium-derived vasoactive peptides, ET and Am, and their interaction. Moreover, we investigated whether alteration of [Ca2+]i due to oxidative stress contributes to ET production or not.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials.
Human Am was obtained from the Peptide Institute (Osaka, Japan).
Menadion sodium bisulfite (MSB),
NG-nitro-L-arginine methyl ester
(L-NAME), catalase, 8-bromo-cAMP (8-Br-cAMP), 8-Br-cGMP,
actinomycin D, forskolin, fura 2-acetoxymethyl ester (AM), ionomycin,
A-23187, thapsigargin (TSG), EGTA,
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
(BAPTA), and cremophor EL were purchased from Sigma (St. Louis, MO).
H2O2 was purchased from Santoku (Tokyo, Japan).
We purchased dl-
-tocopherol from Nacalai Tesque (Kyoto, Japan).
Cell culture. Bovine artery endothelial cells (BAECs) were isolated from the adult bovine carotid artery by digestion with collagenase and elastase (37). The BAECs were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Hazleton Biologics; Lenexa, KS) with 100 units of penicillin and 0.1 mg/ml streptomycin, as we previously reported. The cultures were maintained at 37° in a humidified atmosphere of 95% O2-5% CO2. BAECs harvested between passages 8 and 16 were used in the experiments.
Preparation of conditioned media.
BAECs were grown to confluence in 12-well dishes in DMEM supplemented
with 10% fetal bovine serum. After the medium was changed to DMEM with
0.5% fetal bovine serum, the BAECs were treated with 0.25-0.75 mM
H2O2 for specific periods. MSB (0.25-1.0
mM), a redox cycling drug, was also administered for 3 h to
examine the effect of oxidative stress. To investigate the effect of
antioxidants, the cells were pretreated with catalase, a specific
reductase of H2O2, and
dl-
-tocopherol for 30 min before the addition of H2O2. To address the effect of cAMP and
cAMP-elevating agents on ET secretion from BAECs, the cells were
treated with 8-Br-cAMP, Am, and forskolin. To examine the effect of
[Ca2+]i elevation on ET production, ionomycin
and TSG were added. The harvested supernatants were stored at
20°.
The BAECs were enumerated after incubation with or without
H2O2 to confirm cell viability under oxidative stress.
Radioimmunoassay for ET-1 and Am. After incubation, the concentrations of ET and Am in the media were measured by specific radioimmunoassays (RIAs) developed by us (30, 33). In the RIA for ET-1, the cross-reactivities with ET-2, ET-3, and Big ET-1 were 100%, 60%, and 100% on a molar basis, respectively. A concentration giving half-maximal response (EC50) was achieved at a concentration of 2.4 fmol/tube and minimal inhibition was detected at 0.2 fmol/tube. H2O2 had no effect on ET-like immunoreactivity during the assay. We measured synthetic ET (22 pg/tube) and the same amount of ET mixed with 5 µM H2O2 by RIA and compared the ET-like immunoreactivity. The ET-like immunoreactivity in the tube containing synthetic ET only was 22.4 ± 0.4 pg/tube (n = 4) and that containing synthetic ET and 5 µM H2O2 was 22.9 ± 0.3 (n = 4). In the RIA for Am, the cross-reactivity with calcitonin gene-related peptide-1, which has structual homology with Am, was <0.01%. EC50 was achieved at a concentration of 8.0 fmol/tube and minimal inhibition was detected at 1.0 fmol/tube.
RNA extraction and Northern blot analysis.
BAECs grown to confluence in 10-cm dishes were incubated with
several agents for specific periods. Total cellular RNA was extracted
by a method previously reported (36). RNA samples (25 µg) were applied to 1.0% formamide-agarose gels and transferred to a
nitrocellulose membrane. The samples were then hybridized using rat
ET-1 full-length cDNA or bovine Am partial-length cDNA, prepared by
polymerase chain reaction by using the sense (408-428 bases;
5'-GCAGCCCGCATCCGAGTCAAG-3') and antisense (602- 622 bases; 5'-GTAATAGAGTCCGACCCAAGC-3') primers as probes. The probes were labeled by random priming with [
-32P]-deoxycytidine
5'-triphosphate. The blot was washed finally with 0.1× saline-sodium
citrate buffer at 65°C. Blots were exposed to an imaging plate (Fuji
Film, Japan) for 24 h. The signals on the imaging plate were
quantified with an image analyzer (BAS2000, Fuji Film) and expressed by
the intensity of photo-stimulated luminescence (PSL). The background
PSL values were subtracted. PSL is proportional to the adsorbed
radiation energy on the imaging plate. The main signals, with a size of
2.3 Kb, were quantified. The density of 18S rRNA stained with ethidium
bromide was used to monitor the amount of total RNA in each sample.
Half-life study of ET-1 mRNA. BAECs were incubated in the presence of 10 µg/ml actinomycin D for specific periods, at which time total RNA was extracted. In parallel, the cells were coincubated with actinomycin D and 0.5 mM H2O2 for the same period.
cAMP measurement. Basal and H2O2-stimulated cAMP production in the medium were measured by RIA as described (30). After incubation for 24 h with or without H2O2, the supernatants were collected, succinylated, and mixed with assay buffer. The treated samples were measured with the use of a commercial kit (Yamasa; Tokyo, Japan).
Effects of monoclonal anti-CNP and anti-Am antibodies. To examine the action of endogenous CNP and Am, we utilized a monoclonal anti-CNP antibody (KY-CNP-1) and a monoclonal anti-Am antibody (KY-Am-1), which we previously developed (12, 30). These antibodies in ascites were purified with an Affi-Gel Protein A MAPS II kit (Bio-Rad; Richmond, CA) (30). The neutralizing effects of KY-CNP-1 (10 µg/ml) and KY-Am-1 (50 µg/ml) were confirmed by blockade of CNP-stimulated cGMP production in cultured VSMCs and the Am-induced cAMP elevation in BAECs, respectively (7, 23). The same concentration of mouse immunoglobulin (50 µg/ml, Sigma) was used as a control.
Measurement of [Ca2+]i. [Ca2+]i was measured as described elsewhere (9). Briefly, the BAECs seeded and grown to confluence on the coverslips were loaded with 2 µM fura 2-AM and 0.01% cremophor EL for 30 min at room temperature in modified Hanks' balanced salt solution composed of (in mM) 137 NaCl, 3.5 KCl, 0.44 KH2PO4, 25 NaHCO3, 0.33 Na2HPO4, and 0.5 CaCl2 with a pH of 7.4. The cells were then washed three times with fresh Hanks' balanced salt solution and incubated for 20 min at 37°C. The coverslips were mounted on the stage of a microscope (Diaphot, Nikon; Tokyo, Japan) that was fitted with a charge-coupled device imaging system (Hamamatsu Photonics; Hamamatsu, Japan). The cells were continuously superfused at 3 ml/min with Hanks' balanced salt solution, to which H2O2 was added.
Statistics. Data are presented as means ± SE. The significance of differences between groups was evaluated by repeated-measure analysis of variance, followed by Fisher's protected least-significant difference test. A value of P < 0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
H2O2 decreased ET secretion and
suppressed ET-1 mRNA expression.
Figure 1A illustrates the
effect of H2O2 on ET secretion from BAECs. A
significant decrease in ET secretion was first detectable 3 h
after exposure to 0.5 mM H2O2 and was
maintained for up to 24 h (P < 0.01 vs. basal
secretion, n = 6). At each time point, ~50%
suppression compared with control was observed in response to treatment
with H2O2. Three hours after the administration
of H2O2 (0.25-0.75 mM), ET secretion was
suppressed in a dose-dependent manner, and EC50 was ~0.5
mM, as shown in Fig. 1C (P < 0.01 vs. basal
secretion, n = 6). Twenty-four hours of incubation with 0.5 mM of H2O2 did not significantly affect the
cell number.
|
MSB decreased ET secretion.
Treatment with MSB mimicked the suppressive effect of
H2O2 on ET secretion. Administration of
0.25-1.0 mM MSB for 3 h remarkably suppressed ET secretion
from BAECs in a concentration-dependent manner (Fig.
2, P < 0.01 vs. basal
secretion, n = 3). MSB (0.25 mM) suppressed ET
secretion by 40% compared with the control.
|
Antioxidants prevented H2O2-induced
decrease of ET secretion.
Pretreatment with 300 U/ml of catalase completely abrogated the
H2O2-induced decrease in ET secretion (Fig.
3, P < 0.01 vs. H2O2 treatment, n = 6).
Catalase alone slightly augmented the basal secretion of ET
(P < 0.05 vs. basal secretion, n = 6).
Pretreatment with 50 µg/ml dl-
-tocopherol also
significantly attenuated the H2O2-induced
decrease of ET secretion (Fig. 3, P < 0.05 vs.
H2O2 treatment, n = 4).
|
H2O2 increased Am secretion and Am mRNA
expression with augmentation of cAMP production.
Basal Am secretion from BAECs incubated for 24 h without any
treatment was 8.1 ± 0.2 × 102
fmol/105 cells (n = 4). Treatment with 0.5 mM of H2O2 augmented Am secretion to 14.2 ± 0.5 × 102 fmol/105 cells, as shown in
Fig. 4A (P < 0.05 vs. basal secretion, n = 4). Am mRNA expression
was also augmented by ~30% with 24-h treatment of 0.5 mM
H2O2 compared with the control (Fig.
4B). Figure 4C showed that the addition of
0.25-0.75 mM of H2O2 resulted in
dose-dependent increases of cAMP production for 24 h.
H2O2 (0.5 mM) significantly augmented the cAMP
level in the medium by ~30% compared with the control.
|
Exogenously administered Am and cAMP suppressed ET secretion.
We then investigated the influence of Am and cAMP on ET secretion.
Three hours of treatment with human Am and forskolin, which are well
known to increase the intracellular cAMP levels, attenuated ET
production from BAECs in a dose-dependent manner (Fig.
5, A and B;
P < 0.01 vs. basal secretion, n = 6)
and this effect continued for up to 24 h (data not shown). As
shown in Fig. 5C, addition of 8-Br-cAMP resulted in a
dose-dependent decrease of ET secretion from BAECs (P < 0.01 vs. basal secretion, n = 6).
|
Neutralizing Am monoclonal antibody attenuated
H2O2-induced suppression of ET secretion.
To examine the significance of Am secreted from BAECs on ET secretion,
we performed neutralization experiments with KY-Am-1 on
H2O2-induced suppression of ET secretion.
Treatment with 50 µg/ml KY-Am-1 for 12 and 24 h, respectively,
completely inhibited the suppressive effect of
H2O2, whereas control mouse immunoglobulin did
not affect ET levels (Fig. 6;
P < 0.01 vs. basal secretion, n = 12). KY-Am-1 alone significantly increased ET secretion
compared with the control.
|
Role of cGMP pathway in ET secretion under oxidative stress.
A few studies (13) suggested that NO inhibited ET
secretion by elevating cGMP production in VSMCs. We therefore
investigated the influence of NO and cGMP on ET secretion in the
presence of H2O2. Administration of 10 µM
8-Br-cGMP for 3 and 24 h, respectively, decreased ET secretion
from BAECs to approximately one-half of that seen with the control (3 h, control, 2.41 ± 0.07, 1.57 ± 0.17; and 24 h,
control, 10.79 ± 0.78; 5.82 ± 0.51, ×102
fmol/105 cells, P < 0.01 vs. basal
secretion, n = 3). On the other hand, pretreatment with
10 and 100 µM L-NAME did not affect basal ET secretion or
H2O2-induced suppression of ET secretion (Fig.
7).
|
H2O2 transiently increased
[Ca2+]i and ionomycin and
TSG suppressed ET production in BAEC.
Treatment with Am monoclonal antibody abrogated the
H2O2-induced alteration of ET secretion for 12 or 24 h; however, it had no effect on ET secretion at 3 h
(data not shown). To examine whether an increase in
[Ca2+]i affects ET production, we measured
[Ca2+]i under oxidative stress. As shown in
Fig. 8A, treatment with 1 mM
of H2O2 markedly increased
[Ca2+]i. Furthermore, ionomycin, a
Ca2+ ionophore, and TSG, an inhibitor of endoplasmic
reticulum ATPase, suppressed ET secretion dose dependently (Fig. 8,
B and C). On the other hand, EGTA and BAPTA had
no effect on H2O2-induced suppresion of ET
secretion and ET-1 mRNA expression (data not shown).
|
| |
DISUCUSSION |
|---|
|
|
|---|
ROS have been suggested to act as intracellular second messengers affecting gene regulation in various cells (11). In the present study, we demonstrated that ET production was markedly downregulated by oxidative stress. H2O2 suppressed ET production both dose and time dependently. The suppressive effect on ET secretion by MSB is consistent with the effect of H2O2. These results indicate that oxidative stress is a negative regulator of ET secretion. Treatment with catalase, the specific reductase of H2O2, not only inhibited H2O2-induced suppression of ET secretion but also significantly augmented basal ET secretion, implying that ECs are constantly exposed to oxidative stress at a certain level.
ECs are continuously subjected to flow-induced shear stress. Some studies (2, 4) recently reported that shear stress caused a sustained activation of prooxidant processes, resulting in redox-sensitive gene expression in human ECs, and that this activation was significantly attenuated by pretreatment with antioxidants. We have already shown that shear stress at a physiological level suppressed the production of ET and mRNA expression of ET-converting enzyme-1 (28). From our preliminary results, shear stress-induced downregulation of ET and ET-converting enzyme-1 suppression is blocked on pretreatment with N-acetyl-cystein, an antioxidant. These findings and our results indicate that ET production may be modulated via a redox-sensitive mechanism in the physiological state in vivo.
In the present study, we assessed ET-1 mRNA stability under oxidative stress by using actinomycin D. Inoue et al. (16) reported that the AUUUA motif, considered to be an RNA-destabilizing element, was found in the 3' untranslated region of ET-1 mRNA. In the current study, the ET-1 mRNA half-life was ~20 min in both the presence and the absence of 0.5-mM H2O2. This indicates that H2O2 did not significantly alter the ET-1 mRNA half-life, suggesting that the downregulation of ET-1 mRNA under oxidative stress was modulated at the transcriptional level.
In previous studies (17), administration of
interleukin-
, tumor necrosis factor-
, phorbol ester, oxidized
low-density lipoprotein, and lysophosphatidyl choline, which are well
recognized to generate intracellular ROS, elevated Am production in
cultured rat ECs. In the current study, we obtained direct evidence
that Am secretion and Am mRNA expression were augmented by oxidative stress. Am exerts several actions through augmentation of cAMP production. In the present study, H2O2
increased cAMP production in a dose-dependent fashion. In addition,
both 8-Br-cAMP and forskolin, as well as Am, suppressed ET secretion
from BAECs dose dependently. We further demonstrated that treatment
with a neutralizing monoclonal antibody against Am inhibited the
suppressive effect of H2O2 on ET secretion for
24 h. These results indicate that Am secretion enhanced by
oxidative stress inhibited ET secretion via a cAMP-dependent process in BAECs.
However, the neutralizing monoclonal antibody against Am failed to prevent H2O2-induced suppression of ET secretion at 3 h. Because some reports demonstrated the suppressive effect of increase in [Ca2+]i on ET production in ECs, we investigated the role of intracellular Ca2+ in ET secretion. As shown in Fig. 8, H2O2 markedly increased [Ca2+]i. Furthermore, ionomycin and TSG significantly suppressed ET secretion dose dependently. This effect seems to be dependent on intracellular Ca2+ fluxes because EGTA and BAPTA had no effect on ET production with or without H2O2. These results suggest that H2O2 suppressed ET secretion also via an increase in [Ca2+]i in BAECs.
NO is known to produce cGMP in ECs through activation of soluble guanylate cyclase. It is reported that elevation of the cGMP levels in ECs inhibits ET secretion. Moreover, it is well established that an increase in [Ca2+]i stimulates NO synthesis in ECs. A previous report (34) indicated that treatment with 1.0 mM H2O2 increase [Ca2+]i and enhanced NO synthase (NOS) activity in ECs, leading to cell injury. Another group demonstrated that treatment with 1.0 and 10.0 mM H2O2 increased endothelial NOS (eNOS) tyrosine-phosphorylation and its interaction with caveolin-1, the coat protein of caveolae (8). On the other hand, Gupta et al. (10) demonstrated that in intact ECs, 0.1-0.5 mM of H2O2 had little effect on NOS activity. To determine the possible involvement of the NO-cGMP pathway in the suppression of ET secretion by H2O2, we examined the effect of L-NAME. There was no difference in ET secretion between control and L-NAME-treated BAECs. In our previous study (3), inducible NOS and eNOS expression were not significantly altered by the treatment with 0.25-0.75 mM of H2O2. These findings suggest that, whereas higher concentrations of H2O2 induce NOS activation by extracellular Ca2+ influx, activation of NOS at a level high enough to cause suppression of ET secretion may not occur in ECs in response to lower concentrations of H2O2 as used in the present study.
We have already shown that CNP induces growth inhibition and redifferentiation of proliferating and dedifferentiated VSMCs (6). We also demonstrated that CNP has the ability to potently augment intracellular cGMP accumulation by binding to the atrial natriuretic peptide-B receptor, which has been shown (23) to be selectively activated by CNP in VSMCs. We have previously (3) revealed that H2O2 caused up to a ninefold increase of CNP secretion from BAECs. Therefore, we examined the effect of the CNP neutralizing monoclonal antibody to investigate the possible involvement of the CNP-cGMP pathway in H2O2-induced suppression of ET production. The addition of anti-CNP monoclonal antibody KY-CNP-1, however, failed to prevent H2O2-induced suppression of ET secretion. It could be speculated that atrial natriuretic peptide-B receptor expression is very scarce in ECs, which we previously reported (35).
Our findings suggest that ECs possess the coordinate gene regulation mechanism to reduce the vasoconstricting peptide (ET) secretion and to increase the vasorelaxant peptide (Am) production in response to oxidative stress. By this mechanism, ECs function to protect against oxidative stress by increasing blood flow via VSMC relaxation and growth inhibition.
| |
ACKNOWLEDGEMENTS |
|---|
We thank A. Sone, A. Nonoguchi, and Y. Takada for excellent secretarial work.
| |
FOOTNOTES |
|---|
This work was supported in part by research grants from the Japanese Ministry of Education, Science and Culture, Japanese Ministry of Health, Japan Smoking Foundation, and Japanese Society for the Promotion of Science "Research for the Future" Program Grants JSPS-RFTF 96100204 and JSPS-RFTF 98L00801.
Address for reprint requests and other correspondence: H. Itoh, Dept. of Medicine and Clinical Science, Kyoto Univ. Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan (E-mail address: hiito{at}kuhp.kyoto-u.ac.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 27 April 2000; accepted in final form 15 May 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Chini, EN,
Chini CC,
Bolliger C,
Jougasaki M,
Grande JP,
Burnett JC, Jr,
and
Dousa TP.
Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway.
Kidney Int
52:
917-925,
1997[Web of Science][Medline].
2.
Chiu, JJ,
Wung BS,
Shyy JY,
Hsieh HJ,
and
Wang DL.
Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells.
Arterioscler Thromb Vasc Biol
17:
3570-3577,
1997
3.
Chun, TH,
Itoh H,
Saito T,
Yamahara K,
Doi K,
Mori Y,
Ogawa Y,
Yamashita J,
Tanaka T,
Inoue M,
Masatsugu K,
Sawada N,
Fukunaga Y,
and
Nakao K.
Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin.
J Hypertens
18:
575-580,
2000[Web of Science][Medline].
4.
De Keulenaer, GW,
Chappell DC,
Ishizaka N,
Nerem RM,
Alexander RW,
and
Griending KK.
Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase.
Circ Res
82:
1094-1101,
1998
5.
Dohi, Y,
Hahn AW,
Boulanger CM,
Buhler FR,
and
Luscher TF.
Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.
Hypertension
19:
131-137,
1992
6.
Doi, K,
Itoh H,
Ikeda T,
Hosoda K,
Ogawa Y,
Igaki T,
Yamashita J,
Chun TH,
Inoue M,
Masatsugu K,
Omori K,
and
Nakao K.
Adenovirus-mediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells.
Biochem Biophys Res Commun
239:
889-894,
1997[Web of Science][Medline].
7.
Emori, T,
Hirata Y,
Imai T,
Ohta K,
Eguchi S,
and
Marumo F.
Cellular mechanism of thrombin on endothelin-1 biosynthesis and release in bovine endothelial cell.
Biochem Pharmacol
44:
2409-2411,
1992[Web of Science][Medline].
8.
Garcia-Cardena, G,
Fan R,
Stern DF,
Liu J,
and
Sessa WC.
Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1.
J Biol Chem
271:
27237-27240,
1996
9.
Geeraerts, MD,
Ronveaux-Dupal MF,
Lemasters JJ,
and
Herman B.
Cytosolic free Ca2+ and proteolysis in lethal oxidative injury in endothelial cell.
Am J Physiol Cell Physiol
261:
C889-C996,
1991
10.
Gupta, MP,
Steinberg HO,
and
Hart CM.
H2O2 causes endothelial barrier dysfunction without disrupting the arginine-nitric oxide pathway.
Am J Physiol Lung Cell Mol Physiol
274:
L508-L516,
1998
11.
Halliwell, B,
and
Gutteridge JMC
Free Radicals in Biology and Medicine (2nd ed.). Oxford: Clarendon, 1989.
12.
Hama, N,
Itoh H,
Suga S,
Komatsu Y,
Yoshimasa T,
and
Nakao K.
A monoclonal antibody to C-type natriuretic peptide-preparation and application to radioimmunoassay and neutralization experiment.
J Endocrinol
141:
473-479,
1994
13.
Hinson, JP,
Kapas S,
and
Cameron LA.
Differential effects of endogenous and exogenous nitric oxide on the release of endothelin-1 from the intact perfused rat adrenal gland in situ.
FEBS Lett
379:
7-10,
1996[Web of Science][Medline].
14.
Hu, RM,
Levin ER,
Pedram A,
and
Frank HJ.
Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor.
J Biol Chem
267:
17384-17389,
1992
15.
Imai, T,
Hirata Y,
Emori T,
Yanagisawa M,
Masaki T,
and
Marumo F.
Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.
Hypertension
19:
753-757,
1992
16.
Inoue, A,
Yanagisawa M,
Takuwa Y,
Mitsui Y,
Kobayashi M,
and
Masaki T.
The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression.
J Biol Chem
264:
14954-14959,
1989
17.
Isumi, Y,
Shoji H,
Sugo S,
Tochimoto T,
Yoshioka M,
Kangawa K,
Matsuo H,
and
Minamino N.
Regulation of adrenomedullin production in rat endothelial cells.
Endocrinology
139:
838-846,
1998
18.
Itoh, H,
Mukoyama M,
Pratt RE,
Gibbons GH,
and
Dzau VJ.
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.
J Clin Invest
91:
2268-2274,
1993.
19.
Itoh, H,
Pratt RE,
and
Dzau VJ.
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
J Clin Invest
86:
1690-1697,
1990.
20.
Kano, H,
Kohno M,
Yasunari K,
Yokokawa K,
Horio T,
Ikeda M,
Minami M,
Hanehira T,
Takeda T,
and
Yoshikawa J.
Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells.
J Hypertens
14:
209-213,
1996[Web of Science][Medline].
21.
Kitamura, K,
Kangawa K,
Kawamoto M,
Ichiki Y,
Nakamura S,
Matsuo H,
and
Eto T.
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
Biochem Biophys Res Commun
194:
720-725,
1993[Web of Science][Medline].
22.
Kohno, M,
Kano H,
Horio T,
Yokokawa K,
Yasunari K,
and
Takeda T.
Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells.
Hypertension
25:
1185-1190,
1995
23.
Komatsu, Y,
Itoh H,
Suga S,
Ogawa Y,
Hama N,
Kishimoto I,
Nakagawa O,
Igaki T,
Doi K,
Yoshimasa T,
and
Nakao K.
Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition.
Circ Res
78:
606-14,
1996
24.
Komatsu, Y,
Nakao K,
Itoh H,
Suga S,
Ogawa Y,
and
Imura H.
Vascular natriuretic peptide.
Lancet
340:
622,
1992[Web of Science][Medline].
25.
Kurihara, H,
Yoshizumi M,
Sugiyama T,
Takaku F,
Yanagisawa M,
Masaki T,
Hamaoki M,
Kato H,
and
Yazaki Y.
Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells.
Biochem Biophys Res Commun
159:
1435-1440,
1989[Web of Science][Medline].
26.
Lamas, S,
Michel T,
Collins T,
Brenner BM,
and
Marsden PA.
Effect of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells.
J Clin Invest
90:
879-887,
1992.
27.
Lewis, MS,
Whatley RE,
Chain P,
Mclntyre TM,
Prescott SM,
and
Zimmerman GA.
Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion.
J Clin Invest
82:
2045-2055,
1988.
28.
Masatsugu, K,
Itoh H,
Chun TH,
Ogawa Y,
Tamura N,
Yamashita J,
Doi K,
Inoue M,
Fukunaga Y,
Sawada N,
Saito T,
Korenaga R,
Ando J,
and
Nakao K.
Physiologic shear stress suppressed endothelin-converting enzyme-1 expression in vascular endothelial cells.
J Cardiovasc Pharmacol Suppl
31:
S42-S45,
1998.
29.
Michael, JR,
Markewitz BA,
and
Kohan DE.
Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells.
Am J Physiol Lung Cell Mol Physiol
273:
L768-L774,
1997
30.
Michibata, H,
Mukoyama M,
Tanaka I,
Suga S,
Nakagawa M,
Ishibashi R,
Goto M,
Akaji K,
Fujiwara Y,
Kiso Y,
and
Nakao K.
Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells.
Kidney Int
53:
979-985,
1998[Web of Science][Medline].
31.
Mitchell, MD,
Branch DW,
Lamarche S,
and
Dudley DJ.
The regulation of endothelin production in human umbilical vein endothelial cells: unique inhibitory action of calcium ionophore.
J Clin Endocrinol Metab
75:
665-668,
1992[Abstract].
32.
Oliver, FJ,
de le Rubia G,
Feener EP,
Lee ME,
Loeken MR,
Shiba T,
Quertermous T,
and
King GL.
Stimulation of endothelin-1 gene expression by insulin in endothelial cells.
J Biol Chem
266:
23251-23256,
1991
33.
Saito, Y,
Nakao K,
Itoh H,
Yamada T,
Mukoyama M,
Arai H,
Hosoda K,
Shirakami G,
Suga S,
Jougasaki M,
Morichika S,
and
Imura H.
Endothelin in human plasma and culture medium of aortic endothelial cells-detection and characterization with radioimmunoassay using monoclonal antibody.
Biochem Biophys Res Commun
161:
320-6,
1989[Web of Science][Medline].
34.
Shimizu, S,
Nomoto M,
Naito S,
Yamamoto T,
and
Momose K.
Stimulation of nitric oxide synthase during oxidative endothelial cell injury.
Biochem Pharmacol
55:
77-83,
1998[Web of Science][Medline].
35.
Suga, S,
Itoh H,
Komatsu Y,
Ishida H,
Igaki T,
Yamashita J,
Doi K,
Chun TH,
Yoshimasa T,
Tanaka I,
and
Nakao K.
Regulation of endothelial production of C-type natriuretic peptide by interaction between endothelial cells and macrophages.
Endocrinology
139:
1920-1926,
1998
36.
Suga, S,
Itoh H,
Komatsu Y,
Ogawa Y,
Hama N,
Yoshimasa T,
and
Nakao K.
Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells. Evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells.
Endocrinology
133:
3038-3041,
1993
37.
Suga, S,
Nakao K,
Itoh H,
Komatsu Y,
Ogawa Y,
Hama N,
and
Imura H.
Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-
; possible existence of vascular natriuretic peptide system.
J Clin Invest
90:
1145-1149,
1992.
38.
Whorton, AR,
Montgomery ME,
and
Kent RS.
Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cell.
J Clin Invest
76:
295-302,
1985.
39.
Yanagisawa, M,
Kurihara H,
Kimura S,
Tomobe Y,
Kobayashi M,
Mitsui Y,
Yazaki Y,
Goto K,
and
Masaki T.
A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
Nature
332:
411-415,
1988[Medline].
40.
Zweier, JL,
Kuppusamy P,
and
Lutty GA.
Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.
Proc Natl Acad Sci USA
85:
4046-4050,
1988
This article has been cited by other articles:
![]() |
A. Mak, B. M. Y. Cheung, C. C. Mok, R. Leung, and C. S. Lau Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus Rheumatology, October 1, 2006; 45(10): 1266 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Davis, G. Valacchi, E. Pagnin, Q. Shao, H. B. Gross, L. Calo, and W. Yokoyama Walnuts Reduce Aortic ET-1 mRNA Levels in Hamsters Fed a High-Fat, Atherogenic Diet J. Nutr., February 1, 2006; 136(2): 428 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cuesta, A. Martinez, F. Cuttitta, and E. Zudaire Identification of Adrenomedullin in Avian Type II Pneumocytes: Increased Expression after Exposure to Air Pollutants J. Histochem. Cytochem., June 1, 2005; 53(6): 773 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Pollock Endothelin, Angiotensin, and Oxidative Stress in Hypertension Hypertension, April 1, 2005; 45(4): 477 - 480. [Full Text] [PDF] |
||||
![]() |
K. M. Rogers, C. A. Bonar, J. L. Estrella, and S. Yang Inhibitory effect of glucocorticoid on coronary artery endothelial function Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1922 - H1928. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |